Lupus Therapeutics

preview_player
Показать описание
Al Roy, Executive Director of Lupus Research Alliance affiliate Lupus Therapeutics, speaks to the importance of diversity in lupus clinical trials. Without diversity in clinical trials drug efficacy cannot be assured for all and treatment options will be limited for many lupus patients.

Lupus affects millions worldwide, and there is no cure. Please help the Lupus Research Alliance to raise awareness and funds for lupus research.

Follow Us:
Рекомендации по теме